Pregabalin 72658-0813-01
- Manufacturer
- Eskayef Pharmaceuticals Limited
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- April 4, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA212988
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pregabalin | 225 mg/1 |
Selected Package
72658-0813-01Selected60 CAPSULE in 1 BOTTLE (72658-0813-1)
Other packages for this product(2)
90 CAPSULE in 1 BOTTLE (72658-0813-2)
500 CAPSULE in 1 BOTTLE (72658-0813-6)